1-5 of 5
Authors: Esther Heijnen
Journal Article
Concomitant Administration of Ad26.RSV.preF/RSV preF Protein Vaccine and High-Dose Influenza Vaccine in Adults 65 Years and Older: A Noninferiority Trial Open Access
The Journal of Infectious Diseases, Volume 230, Issue 2, 15 August 2024, Pages e374–e383, https://doi.org/10.1093/infdis/jiad594
Published: 22 December 2023
Journal Article
Safety, Immunogenicity, and Regimen Selection of Ad26.RSV.preF–Based Vaccine Combinations: A Randomized, Double-blind, Placebo-Controlled, Phase 1/2a Study Open Access
The Journal of Infectious Diseases, Volume 229, Issue 1, 15 January 2024, Pages 19–29, https://doi.org/10.1093/infdis/jiad220
Published: 11 July 2023
Journal Article
Phase 1/2a Safety and Immunogenicity of an Adenovirus 26 Vector Respiratory Syncytial Virus (RSV) Vaccine Encoding Prefusion F in Adults 18–50 Years and RSV-Seropositive Children 12–24 Months Open Access
The Journal of Infectious Diseases, Volume 227, Issue 1, 1 January 2023, Pages 71–82, https://doi.org/10.1093/infdis/jiac407
Published: 19 October 2022
Journal Article
Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study Open Access
The Journal of Infectious Diseases, Volume 226, Issue 3, 1 August 2022, Pages 396–406, https://doi.org/10.1093/infdis/jiab003
Published: 05 January 2021
Journal Article
Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults Free
The Journal of Infectious Diseases, Volume 223, Issue 4, 15 February 2021, Pages 699–708, https://doi.org/10.1093/infdis/jiaa409
Published: 26 August 2020
